As part of AReNA, Quebec’s RNA Hub, CQDM is seeking a specialized organization or consortium to design, deliver, and operate a support program aimed at accelerating the growth of emerging Quebec biotech companies and advancing them toward a Series A financing round.
The program will support a cohort of companies selected for their growth potential and readiness for institutional investment. Complementing resources already available within the ecosystem, this initiative is intended to strengthen support for biotech companies that have reached an advanced seed-stage of development.
The selected organization will be responsible for leading the program, supporting participating companies, and mobilizing the expertise and strategic networks required to help them achieve key growth milestones.
Desired Profile
CQDM is seeking to partner with an organization or consortium that demonstrates:
- Practical expertise in biotech company development;
- Experience designing and operating programs for early-stage innovative companies in the biotech sector;
- Access to leading industry experts and investor networks;
- A proven approach to accelerating company growth, project maturation, and the achievement of critical milestones.
Submitting an Expression of Interest
Interested organizations may contact CQDM at [email protected] to obtain the respondent guide and submission form.
Submission deadline: September 4, 2026, at 5:00 p.m. EDT.
This expression of interest is a preliminary information-gathering process and does not constitute a request for proposals, tender, or commitment to award a contract.
Frequently Asked Questions
What is AReNA?
AReNA, Quebec’s RNA Hub, was established with the support of the Government of Quebec to bring together the province’s RNA therapeutics initiatives. It is building a collaborative ecosystem that transforms scientific discoveries into accessible solutions, with the goal of positioning Quebec as a leading international hub for RNA innovation.
Who can apply?
Any organization or consortium with expertise in biotech company development may submit an expression of interest, whether based in Quebec, elsewhere in Canada, or internationally.
